UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Looking for ways to generate cash today? Check out fast earning methods that can help you boost your income quickly.
22,309 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Spotify unveiled a long-term plan to hit 1 billion active users and sustain 20% operating margins by 2030, highlighti...
Two pharma giants are wighting for a leadership position in immunology. This piece explains why Johnson Johnson hopes...
The AI hype has lifted many stocks, but a bubble bursts scenario could knock the S&P 500 lower. This guide shows how ...
A space-focused Nasdaq-100 entrant is drawing attention after earnings and a key index promotion. Investors see a pot...
AI is reshaping business, and a few durable names stand to benefit for years. Here are three artificial intelligence ...
Bank of America Securities unveils four US Q3 ideas that fuse dividend income with double-digit upside potential. The...
Rising costs and higher rates are pressuring traditional bonds. More retirees replacing bond allocations with dividen...
When a top executive sells a large block of stock, investors want to know whether it signals trouble or simply person...
As Alphabet treads into 2026, three driving forces could shape its trajectory: AI-powered growth, smarter ads monetiz...
The founder is back at Simply Good Foods, triggering a shift in market mood as insiders buy and Reddit chatter tilts ...
Ondas Holdings rides a Mistral merger to prime DoD contractor status, unlocking access to more than $1 billion in def...